Johnson & Johnson (LON:0R34)

Market Cap	304.75B
Revenue (ttm)	70.55B
Net Income (ttm)	11.17B
Shares Out	n/a
EPS (ttm)	4.60
PE Ratio	27.28
Forward PE	n/a
Dividend	3.88 (2.38%)
Ex-Dividend Date	Feb 18, 2025

Volume	3,696
Average Volume	19,715
Open	161.77
Previous Close	161.80
Day's Range	161.32 - 164.01
52-Week Range	143.14 - 165.71
Beta	n/a
RSI	56.71
Earnings Date	Apr 15, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R34

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD